{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:31:46Z","timestamp":1786991506234,"version":"build-2736575974"},"reference-count":175,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.jaut.2021.102609","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T08:55:28Z","timestamp":1613552128000},"page":"102609","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Immune-mediated enteropathies: From bench to bedside"],"prefix":"10.1016","volume":"118","author":[{"given":"Roy L.J.","family":"van Wanrooij","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hetty J.","family":"Bontkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Andra","family":"Neefjes-Borst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris J.","family":"Mulder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Bouma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2021.102609_bib1","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1398-9995.2010.02519.x","article-title":"Adaptive T-cell responses regulating oral tolerance to protein antigen","volume":"66","author":"du Pre","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jaut.2021.102609_bib2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0065-3101(22)00464-9","article-title":"Celiac disease","volume":"9","author":"Dicke","year":"1957","journal-title":"Adv. Pediatr."},{"key":"10.1016\/j.jaut.2021.102609_bib3","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1586\/17474124.2015.1039990","article-title":"Identification of new cases of severe enteropathy has recently increased the spectrum of intestinal non-celiac villous atrophy","volume":"9","author":"Malamut","year":"2015","journal-title":"Expet Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jaut.2021.102609_bib4","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.mayocp.2012.06.003","article-title":"Severe spruelike enteropathy associated with olmesartan","volume":"87","author":"Rubio-Tapia","year":"2012","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.jaut.2021.102609_bib5","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1182\/blood-2013-07-512830","article-title":"Indolent T-cell lymphoproliferative disease of the gastrointestinal tract","volume":"122","author":"Perry","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2021.102609_bib6","doi-asserted-by":"crossref","first-page":"557","DOI":"10.3109\/07853890.2010.523229","article-title":"Are we not over-estimating the prevalence of coeliac disease in the general population?","volume":"42","author":"Biagi","year":"2010","journal-title":"Ann. Med."},{"key":"10.1016\/j.jaut.2021.102609_bib7","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3109\/00365529509101610","article-title":"Gender and clinical presentation in adult celiac disease","volume":"30","author":"Ciacci","year":"1995","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.jaut.2021.102609_bib8","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0140-6736(99)02609-4","article-title":"Why is coeliac disease endemic in the people of the Sahara?","volume":"354","author":"Catassi","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2021.102609_bib9","doi-asserted-by":"crossref","first-page":"441","DOI":"10.15403\/jgld.2014.1121.254.gil","article-title":"Celiac disease in The Netherlands: demographic data of members of the Dutch celiac society","volume":"25","author":"van Gils","year":"2016","journal-title":"J. Gastrointestin Liver Disease"},{"key":"10.1016\/j.jaut.2021.102609_bib10","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrgastro.2010.23","article-title":"The spectrum of celiac disease: epidemiology, clinical aspects and treatment","volume":"7","author":"Tack","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jaut.2021.102609_bib11","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1136\/gut.2005.083964","article-title":"Concordance, disease progression, and heritability of coeliac disease in Italian twins","volume":"55","author":"Nistico","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2021.102609_bib12","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMra071600","article-title":"Celiac disease","volume":"357","author":"Green","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2021.102609_bib13","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/ng.998","article-title":"Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease","volume":"43","author":"Trynka","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jaut.2021.102609_bib14","doi-asserted-by":"crossref","first-page":"144165","DOI":"10.1016\/j.gene.2019.144165","article-title":"Celiac disease associated SNP rs17810546 is located in a gene silencing region","volume":"726","author":"Zwiers","year":"2020","journal-title":"Gene"},{"key":"10.1016\/j.jaut.2021.102609_bib15","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/ncpgasthep0582","article-title":"Mechanisms of disease: immunopathogenesis of celiac disease","volume":"3","author":"Jabri","year":"2006","journal-title":"Nat. Clin. Pract. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jaut.2021.102609_bib16","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/mi.2010.36","article-title":"HLA-DQ2-restricted gluten-reactive T cells produce IL-21 but not IL-17 or IL-22","volume":"3","author":"Bodd","year":"2010","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.jaut.2021.102609_bib17","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.4049\/jimmunol.1601693","article-title":"T cells in celiac disease","volume":"198","author":"Jabri","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2021.102609_bib18","first-page":"285","article-title":"Intraepithelial lymphocytes and coeliac disease: permanent changes in CD3-\/CD7+ and T cell receptor gammadelta subsets studied by flow cytometry","volume":"89","author":"Camarero","year":"2000","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.jaut.2021.102609_bib19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-2249.1991.tb05690.x","article-title":"Gamma\/delta T cells and the diagnosis of coeliac disease","volume":"85","author":"Spencer","year":"1991","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2021.102609_bib20","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.cell.2018.12.039","article-title":"Chronic inflammation permanently reshapes tissue-resident immunity in celiac disease","volume":"176","author":"Mayassi","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2021.102609_bib21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1126\/science.aah5298","article-title":"Reovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease","volume":"356","author":"Bouziat","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.jaut.2021.102609_bib22","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.cgh.2016.10.033","article-title":"Factors that increase risk of celiac disease autoimmunity after a gastrointestinal infection in early life","volume":"15","author":"Kemppainen","year":"2017","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jaut.2021.102609_bib23","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/08830185.2011.595854","article-title":"An update on the diagnostics of celiac disease","volume":"30","author":"Lindfors","year":"2011","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.jaut.2021.102609_bib24","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1053\/j.gastro.2015.01.044","article-title":"Advances in diagnosis and management of celiac disease","volume":"148","author":"Kelly","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2021.102609_bib25","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/j.1572-0241.2002.05612.x","article-title":"The insensitivity of endoscopic markers in celiac disease","volume":"97","author":"Oxentenko","year":"2002","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jaut.2021.102609_bib26","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1097\/00042737-199910000-00019","article-title":"The histopathology of coeliac disease: time for a standardized report scheme for pathologists","volume":"11","author":"Oberhuber","year":"1999","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jaut.2021.102609_bib27","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1136\/gut.2005.071514","article-title":"Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits","volume":"55","author":"Salmi","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2021.102609_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fmed.2014.00009","article-title":"Beyond the intestinal celiac mucosa: diagnostic role of anti-TG2 deposits, a systematic review","volume":"1","author":"Gatti","year":"2014","journal-title":"Front. Med."},{"key":"10.1016\/j.jaut.2021.102609_bib29","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/MPG.0b013e3181677067","article-title":"Immunoglobulin A anti-tissue transglutaminase antibody deposits in the small intestinal mucosa of children with no villous atrophy","volume":"47","author":"Tosco","year":"2008","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.jaut.2021.102609_bib30","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1053\/j.gastro.2017.11.006","article-title":"HLA-DQ-Gluten tetramer blood test accurately identifies patients with and without celiac disease in absence of gluten consumption","volume":"154","author":"Sarna","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2021.102609_bib31","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/apt.12621","article-title":"Predictors of persistent villous atrophy in coeliac disease: a population-based study","volume":"39","author":"Lebwohl","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.jaut.2021.102609_bib32","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/ajcn\/79.4.669","article-title":"Effect of a gluten-free diet on gastrointestinal symptoms in celiac disease","volume":"79","author":"Murray","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.jaut.2021.102609_bib33","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1111\/j.1572-0241.2002.05917.x","article-title":"Etiology of nonresponsive celiac disease: results of a systematic approach","volume":"97","author":"Abdulkarim","year":"2002","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jaut.2021.102609_bib34","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.3748\/wjg.v18.i12.1348","article-title":"Celiac disease: management of persistent symptoms in patients on a gluten-free diet","volume":"18","author":"Dewar","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jaut.2021.102609_bib35","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1053\/gast.1997.v112.pm9178673","article-title":"The prevalence and causes of chronic diarrhea in patients with celiac sprue treated with a gluten-free diet","volume":"112","author":"Fine","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2021.102609_bib36","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.cgh.2006.12.006","article-title":"Etiologies and predictors of diagnosis in nonresponsive celiac disease","volume":"5","author":"Leffler","year":"2007","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jaut.2021.102609_bib37","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1038\/ctg.2016.70","article-title":"Outcome of referrals for non-responsive celiac disease in a tertiary center: low incidence of refractory celiac disease in The Netherlands","volume":"8","author":"van Wanrooij","year":"2017","journal-title":"Clin. Transl. Gastroenterol."},{"key":"10.1016\/j.jaut.2021.102609_bib38","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/MCG.0000000000000392","article-title":"Frequency and cause of persistent symptoms in celiac disease patients on a long-term gluten-free diet","volume":"50","author":"Stasi","year":"2016","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.jaut.2021.102609_bib39","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.bpg.2005.02.001","article-title":"Refractory coeliac disease","volume":"19","author":"Daum","year":"2005","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.jaut.2021.102609_bib40","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1136\/gut.2009.195131","article-title":"Classification and management of refractory coeliac disease","volume":"59","author":"Rubio-Tapia","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2021.102609_bib41","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0016-5085(98)70530-X","article-title":"Abnormal intestinal intraepithelial lymphocytes in refractory sprue","volume":"114","author":"Cellier","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2021.102609_bib42","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1136\/gut.2006.114512","article-title":"Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience","volume":"56","author":"Al-Toma","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2021.102609_bib43","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/j.gastro.2008.09.069","article-title":"Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II","volume":"136","author":"Malamut","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2021.102609_bib44","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1053\/j.gastro.2008.10.013","article-title":"Clinical staging and survival in refractory celiac disease: a single center experience","volume":"136","author":"Rubio-Tapia","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2021.102609_bib45","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/apt.12606","article-title":"Refractory coeliac disease in a country with a high prevalence of clinically-diagnosed coeliac disease","volume":"39","author":"Ilus","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.jaut.2021.102609_bib46","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1053\/j.gastro.2008.11.026","article-title":"Celiac disease and its complications: a time traveller's perspective","volume":"136","author":"West","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2021.102609_bib47","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1136\/gutjnl-2012-302265","article-title":"Identification of a potential physiological precursor of aberrant cells in refractory coeliac disease type II","volume":"62","author":"Schmitz","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2021.102609_bib48","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2016-311816","article-title":"T-cell repertoires in refractory coeliac disease","author":"Ritter","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2021.102609_bib49","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1136\/gutjnl-2014-308153","article-title":"The composition and differentiation potential of the duodenal intraepithelial innate lymphocyte compartment is altered in coeliac disease","volume":"65","author":"Schmitz","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2021.102609_bib50","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00281-012-0322-z","article-title":"Refractory celiac disease: from bench to bedside","volume":"34","author":"Malamut","year":"2012","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.jaut.2021.102609_bib51","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/PAS.0b013e318159b478","article-title":"Mucosal intraepithelial T-lymphocytes in refractory celiac disease: a neoplastic population with a variable CD8 phenotype","volume":"32","author":"de Mascarel","year":"2008","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.jaut.2021.102609_bib52","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.molimm.2012.01.014","article-title":"Origin and immunophenotype of aberrant IEL in RCDII patients","volume":"50","author":"Tack","year":"2012","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jaut.2021.102609_bib53","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/MCG.0b013e31823eff20","article-title":"TCRbeta clonality improves diagnostic yield of TCRgamma clonality in refractory celiac disease","volume":"46","author":"Perfetti","year":"2012","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.jaut.2021.102609_bib54","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1007\/s10875-014-0075-7","article-title":"Optimal strategies to identify aberrant intra-epithelial lymphocytes in refractory coeliac disease","volume":"34","author":"van Wanrooij","year":"2014","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jaut.2021.102609_bib55","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1136\/gut.2010.223438","article-title":"Accurate classification of RCD requires flow cytometry","volume":"59","author":"van Wanrooij","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2021.102609_bib56","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.clim.2007.09.002","article-title":"Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease","volume":"126","author":"Verbeek","year":"2008","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jaut.2021.102609_bib57","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1586\/17474124.2016.1124759","article-title":"Refractory celiac disease","volume":"10","author":"Rishi","year":"2016","journal-title":"Expet Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jaut.2021.102609_bib58","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cgh.2005.12.011","article-title":"Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma","volume":"4","author":"Al-Toma","year":"2006","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jaut.2021.102609_bib59","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1572-0241.2000.01838.x","article-title":"Disappearance of endomysial antibodies in treated celiac disease does not indicate histological recovery","volume":"95","author":"Dickey","year":"2000","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jaut.2021.102609_bib60","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/j.1365-2036.2007.03311.x","article-title":"Persistent small bowel mucosal villous atrophy without symptoms in coeliac disease","volume":"25","author":"Kaukinen","year":"2007","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.jaut.2021.102609_bib61","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/j.1365-2036.2009.03992.x","article-title":"Complete recovery of intestinal mucosa occurs very rarely in adult coeliac patients despite adherence to gluten-free diet","volume":"29","author":"Lanzini","year":"2009","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.jaut.2021.102609_bib62","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1067\/mge.2003.54","article-title":"Duodenal histology in patients with celiac disease after treatment with a gluten-free diet","volume":"57","author":"Lee","year":"2003","journal-title":"Gastrointest. Endosc."},{"key":"10.1016\/j.jaut.2021.102609_bib63","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/ajg.2010.10","article-title":"Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet","volume":"105","author":"Rubio-Tapia","year":"2010","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jaut.2021.102609_bib64","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1309\/EVXT-851X-WHLC-RLX9","article-title":"Histologic follow-up of people with celiac disease on a gluten-free diet: slow and incomplete recovery","volume":"118","author":"Wahab","year":"2002","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.jaut.2021.102609_bib65","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1080\/00365521.2016.1218540","article-title":"Long-term mucosal recovery and healing in celiac disease is the rule - not the exception","volume":"51","author":"Haere","year":"2016","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.jaut.2021.102609_bib66","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/1471-230X-12-159","article-title":"Serum parameters in the spectrum of coeliac disease: beyond standard antibody testing--a cohort study","volume":"12","author":"Tack","year":"2012","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.jaut.2021.102609_bib67","first-page":"258","article-title":"Serum intestinal-fatty acid binding protein as a biomarker for refractory celiac disease","volume":"24","author":"Gross","year":"2015","journal-title":"J. Gastrointestin Liver Disease"},{"key":"10.1016\/j.jaut.2021.102609_bib68","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/MEG.0b013e32835dca77","article-title":"Antibody titers against food antigens decrease upon a gluten-free diet, but are not useful for the follow-up of (refractory) celiac disease","volume":"25","author":"Gross","year":"2013","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jaut.2021.102609_bib69","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1111\/j.1572-0241.2007.01380.x","article-title":"Budesonide in the treatment of refractory celiac disease","volume":"102","author":"Brar","year":"2007","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jaut.2021.102609_bib70","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1159\/000092639","article-title":"Therapy with budesonide in patients with refractory sprue","volume":"73","author":"Daum","year":"2006","journal-title":"Digestion"},{"key":"10.1016\/j.jaut.2021.102609_bib71","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1046\/j.1365-2036.2003.01687.x","article-title":"Azathioprine and prednisone combination therapy in refractory coeliac disease","volume":"18","author":"Goerres","year":"2003","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.jaut.2021.102609_bib72","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1016\/S0002-9270(02)04387-3","article-title":"Azathioprine in refractory sprue: results from a prospective, open-label study","volume":"97","author":"Maurino","year":"2002","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jaut.2021.102609_bib73","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bpg.2009.11.002","article-title":"Enteropathy associated T-cell lymphoma and its precursor lesions","volume":"24","author":"van de Water","year":"2010","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.jaut.2021.102609_bib74","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1182\/blood.V92.10.3879","article-title":"Are complicated forms of celiac disease cryptic T-cell lymphomas?","volume":"92","author":"Carbonnel","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2021.102609_bib75","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(00)02481-8","article-title":"Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group","volume":"356","author":"Cellier","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2021.102609_bib76","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000381076","article-title":"Therapy in RCDII: rationale for combination strategies?","volume":"33","author":"Nijeboer","year":"2015","journal-title":"Dig. Dis."},{"key":"10.1016\/j.jaut.2021.102609_bib77","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.immuni.2016.07.018","article-title":"Interleukin-15-Dependent T-cell-like innate intraepithelial lymphocytes develop in the intestine and transform into lymphomas in celiac disease","volume":"45","author":"Ettersperger","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2021.102609_bib78","doi-asserted-by":"crossref","first-page":"E980","DOI":"10.1073\/pnas.1620036114","article-title":"CD4 T-cell cytokines synergize to induce proliferation of malignant and nonmalignant innate intraepithelial lymphocytes","volume":"114","author":"Kooy-Winkelaar","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2021.102609_bib79","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1172\/JCI41344","article-title":"IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesis","volume":"120","author":"Malamut","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jaut.2021.102609_bib80","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.immuni.2004.06.018","article-title":"A direct role for NKG2D\/MICA interaction in villous atrophy during celiac disease","volume":"21","author":"Hue","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2021.102609_bib81","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/MEG.0000000000001168","article-title":"A locus at 7p14.3 predisposes to refractory celiac disease progression from celiac disease","volume":"30","author":"Hrdlickova","year":"2018","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jaut.2021.102609_bib82","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41419-018-0650-6","article-title":"FAM188B enhances cell survival via interaction with USP7","volume":"9","author":"Choi","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jaut.2021.102609_bib83","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/cyto.b.20481","article-title":"Aberrant T-lymphocytes in refractory coeliac disease are not strictly confined to a small intestinal intraepithelial localization","volume":"76","author":"Verbeek","year":"2009","journal-title":"Cytometry B Clin. Cytom."},{"key":"10.1016\/j.jaut.2021.102609_bib84","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/gut.52.2.205","article-title":"Refractory coeliac sprue is a diffuse gastrointestinal disease","volume":"52","author":"Verkarre","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2021.102609_bib85","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/gut.51.3.372","article-title":"Heterogeneity of intraepithelial lymphocytes in refractory sprue: potential implications of CD30 expression","volume":"51","author":"Farstad","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2021.102609_bib86","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1053\/gast.2002.36585","article-title":"Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis","volume":"123","author":"Askling","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2021.102609_bib87","article-title":"Celiac disease and malignancy","volume":"24","author":"Holmes","year":"1997","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.jaut.2021.102609_bib88","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.dld.2011.07.012","article-title":"Coeliac disease characteristics, compliance to a gluten free diet and risk of lymphoma by subtype","volume":"43","author":"Olen","year":"2011","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.jaut.2021.102609_bib89","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1158\/1078-0432.CCR-14-2195","article-title":"A new and validated clinical prognostic model (EPI) for enteropathy-associated T-cell lymphoma","volume":"21","author":"de Baaij","year":"2015","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.jaut.2021.102609_bib90","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3748\/wjg.v17.i4.506","article-title":"Evaluation of Cladribine treatment in refractory celiac disease type II","volume":"17","author":"Tack","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jaut.2021.102609_bib91","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.cgh.2006.07.007","article-title":"Cladribine therapy in refractory celiac disease with aberrant T cells","volume":"4","author":"Al-Toma","year":"2006","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jaut.2021.102609_bib92","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1177\/2050640616646529","article-title":"Lymphoma development and survival in refractory coeliac disease type II: histological response as prognostic factor","volume":"5","author":"Nijeboer","year":"2017","journal-title":"United Eur. Gastroenterol. J."},{"key":"10.1016\/j.jaut.2021.102609_bib93","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S2468-1253(19)30265-1","article-title":"Safety and efficacy of AMG 714 in patients with type 2 refractory coeliac disease: a phase 2a, randomised, double-blind, placebo-controlled, parallel-group study","volume":"4","author":"Cellier","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.jaut.2021.102609_bib94","doi-asserted-by":"crossref","first-page":"932","DOI":"10.4049\/jimmunol.120.3.932","article-title":"Selective IgA deficiency associated with total villous atrophy of the small intestine and an organ-specific anti-epithelial cell antibody","volume":"120","author":"McCarthy","year":"1978","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2021.102609_bib95","first-page":"375","article-title":"Autoimmunity in diarrhoeal disease","volume":"4","author":"Unsworth","year":"1985","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.jaut.2021.102609_bib96","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.cgh.2007.05.013","article-title":"Adult autoimmune enteropathy: mayo clinic rochester experience","volume":"5","author":"Akram","year":"2007","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jaut.2021.102609_bib97","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0140-6736(97)01042-8","article-title":"Autoimmune enteropathy and villous atrophy in adults","volume":"350","author":"Corazza","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2021.102609_bib98","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0016-5085(99)70340-9","article-title":"Identification of an autoimmune enteropathy-related 75-kilodalton antigen","volume":"117","author":"Kobayashi","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2021.102609_bib99","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.clim.2014.10.010","article-title":"Disease specificity of anti-tryptophan hydroxylase-1 and anti-AIE-75 autoantibodies in APECED and IPEX syndrome","volume":"156","author":"Chida","year":"2015","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jaut.2021.102609_bib100","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1046\/j.1365-2249.2002.01795.x","article-title":"Mechanisms of villous atrophy in autoimmune enteropathy and coeliac disease","volume":"128","author":"Ciccocioppo","year":"2002","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2021.102609_bib101","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1111\/j.1572-0241.2004.40039.x","article-title":"Clinical and immunological features of adult-onset generalized autoimmune gut disorder","volume":"99","author":"Leon","year":"2004","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jaut.2021.102609_bib102","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1080\/00365520902783691","article-title":"Autoimmune enteropathy in children and adults","volume":"44","author":"Montalto","year":"2009","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.jaut.2021.102609_bib103","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1007\/s10620-005-2666-x","article-title":"Adult-onset autoimmune enteropathy in the setting of thymoma successfully treated with infliximab","volume":"50","author":"Elwing","year":"2005","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.jaut.2021.102609_bib104","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.dld.2006.02.003","article-title":"Autoimmune enteropathy and rheumatoid arthritis: a new association in the field of autoimmunity","volume":"38","author":"Volta","year":"2006","journal-title":"Dig. Liver Dis."},{"issue":"6","key":"10.1016\/j.jaut.2021.102609_bib105","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.cgh.2017.12.044","article-title":"Features of adult autoimmune enteropathy compared with refractory celiac disease","volume":"jun;16","author":"Sharma","year":"2018","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jaut.2021.102609_bib106","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1038\/ajg.2009.511","article-title":"Anti-goblet cell antibodies for the diagnosis of autoimmune enteropathy?","volume":"104","author":"Biagi","year":"2009","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jaut.2021.102609_bib107","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.autrev.2014.01.028","article-title":"Diagnosis and classification of ulcerative colitis","volume":"13","author":"Conrad","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2021.102609_bib108","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.autrev.2015.08.004","article-title":"New insights into immune mechanisms underlying autoimmune diseases of the gastrointestinal tract","volume":"14","author":"Di Sabatino","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2021.102609_bib109","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125024","article-title":"Gastrointestinal disorder associated with olmesartan mimics autoimmune enteropathy","volume":"10","author":"Scialom","year":"2015","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.jaut.2021.102609_bib110","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00428-017-2243-7","article-title":"Autoimmune enteropathies","volume":"Jan;472","author":"Umetsu","year":"2017","journal-title":"Virchows Arch"},{"key":"10.1016\/j.jaut.2021.102609_bib111","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.4049\/jimmunol.0802769","article-title":"Intestinal tolerance is converted to autoimmune enteritis upon PD-1 ligand blockade","volume":"182","author":"Reynoso","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2021.102609_bib112","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/PAS.0b013e31817150e3","article-title":"Alpha-CTLA-4 mAb-associated panenteritis: a histologic and immunohistochemical analysis","volume":"32","author":"Oble","year":"2008","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.jaut.2021.102609_bib113","first-page":"108","article-title":"Cerebral venous thrombosis in autoimmune enteropathy","volume":"123","author":"Ranta","year":"2010","journal-title":"N. Z.Med. J."},{"key":"10.1016\/j.jaut.2021.102609_bib114","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1136\/gut.32.11.1421","article-title":"Response to autoimmune enteropathy to cyclosporin A therapy","volume":"32","author":"Sanderson","year":"1991","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2021.102609_bib115","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.14309\/02075970-201805000-00092","article-title":"New treatment option for autoimmune enteropathy: a rare case of intractable diarrhea treated with vedolizumab","volume":"5","author":"Robbins","year":"2018","journal-title":"ACG Case Rep. J."},{"issue":"2","key":"10.1016\/j.jaut.2021.102609_bib116","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/hon.2494","article-title":"Intestinal T-cell lymphoma with enteropathy-associated T-cell lymphoma-like features arising in the setting of adult autoimmune enteropathy","volume":"Apr;36","author":"Ciccocioppo","year":"2018","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.jaut.2021.102609_bib117","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.dld.2012.12.001","article-title":"Enteropathy associated T cell lymphoma in celiac disease: a large retrospective study","volume":"45","author":"Malamut","year":"2013","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.jaut.2021.102609_bib118","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.5858\/arpa.2015-0204-RA","article-title":"Olmesartan-associated enteropathy: a review of clinical and histologic findings","volume":"139","author":"Choi","year":"2015","journal-title":"Arch. Pathol. Lab Med."},{"key":"10.1016\/j.jaut.2021.102609_bib119","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/apt.12937","article-title":"Olmesartan-associated enteropathy: results of a national survey","volume":"40","author":"Marthey","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.jaut.2021.102609_bib120","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/apt.12780","article-title":"Systematic review: sprue-like enteropathy associated with olmesartan","volume":"40","author":"Ianiro","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.jaut.2021.102609_bib121","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.humpath.2015.12.001","article-title":"Olmesartan-associated sprue-like enteropathy: a systematic review with emphasis on histopathology","volume":"50","author":"Burbure","year":"2016","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.jaut.2021.102609_bib122","doi-asserted-by":"crossref","first-page":"253","DOI":"10.5223\/pghn.2015.18.4.253","article-title":"Clinical manifestations and treatment outcomes of eosinophilic gastroenteritis in children","volume":"18","author":"Choi","year":"2015","journal-title":"Pediatr. Gastroenterol. Hepatol. Nutr."},{"key":"10.1016\/j.jaut.2021.102609_bib123","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1136\/gutjnl-2015-309690","article-title":"Severe intestinal malabsorption associated with olmesartan: a French nationwide observational cohort study","volume":"65","author":"Basson","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2021.102609_bib124","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1111\/apt.13413","article-title":"Immunopathogenesis of olmesartan-associated enteropathy","volume":"42","author":"Marietta","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.jaut.2021.102609_bib125","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.bbrc.2012.07.003","article-title":"Angiotensin II induces apoptosis in intestinal epithelial cells through the AT2 receptor, GATA-6 and the Bax pathway","volume":"424","author":"Sun","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jaut.2021.102609_bib126","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1177\/1060028014540608","article-title":"Triple phase\" budesonide capsules for the treatment of olmesartan-induced enteropathy","volume":"48","author":"Hartranft","year":"2014","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.jaut.2021.102609_bib127","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1200\/JCO.2012.41.6750","article-title":"Management of immune-related adverse events and kinetics of response with ipilimumab","volume":"30","author":"Weber","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jaut.2021.102609_bib128","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1634\/theoncologist.2016-0055","article-title":"Management of adverse events following treatment with anti-programmed death-1 agents","volume":"21","author":"Weber","year":"2016","journal-title":"Oncol."},{"key":"10.1016\/j.jaut.2021.102609_bib129","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.mayocp.2013.01.015","article-title":"Association between ipilimumab and celiac disease","volume":"88","author":"Gentile","year":"2013","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.jaut.2021.102609_bib130","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/S0140-6736(00)02880-4","article-title":"Onset of coeliac disease during treatment with interferon for chronic hepatitis C","volume":"356","author":"Cammarota","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2021.102609_bib131","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.3109\/00365521.2011.613950","article-title":"IFN beta 1b induced celiac disease","volume":"46","author":"Fernandez-Salazar","year":"2011","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.jaut.2021.102609_bib132","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1432-2277.2004.tb00471.x","article-title":"Villous atrophy induced by mycophenolate mofetil in renal-transplant patients","volume":"17","author":"Kamar","year":"2004","journal-title":"Transpl. Int."},{"key":"10.1016\/j.jaut.2021.102609_bib133","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1136\/jclinpath-2014-202199","article-title":"Apoptotic enteropathy caused by antimetabolites and TNF-alpha antagonists","volume":"67","author":"Soldini","year":"2014","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.jaut.2021.102609_bib134","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1586\/eci.13.30","article-title":"A review on guidelines for management and treatment of common variable immunodeficiency","volume":"9","author":"Abolhassani","year":"2013","journal-title":"Expet Rev. Clin. Immunol."},{"key":"10.1016\/j.jaut.2021.102609_bib135","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/clim.1999.4725","article-title":"Common variable immunodeficiency: clinical and immunological features of 248 patients","volume":"92","author":"Cunningham-Rundles","year":"1999","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jaut.2021.102609_bib136","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0002-9343(76)90173-X","article-title":"Idiopathic late-onset immunoglobulin deficiency. Clinical observations in 50 patients","volume":"61","author":"Hermans","year":"1976","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jaut.2021.102609_bib137","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1572-0241.2003.07159.x","article-title":"Duodenal pathology and clinical-immunological implications in common variable immunodeficiency patients","volume":"98","author":"Luzi","year":"2003","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jaut.2021.102609_bib138","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1038\/ajg.2010.214","article-title":"The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease","volume":"105","author":"Malamut","year":"2010","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jaut.2021.102609_bib139","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1053\/j.gastro.2006.06.022","article-title":"Excess IL-12 but not IL-23 accompanies the inflammatory bowel disease associated with common variable immunodeficiency","volume":"131","author":"Mannon","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2021.102609_bib140","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.chom.2007.09.013","article-title":"IgA response to symbiotic bacteria as a mediator of gut homeostasis","volume":"2","author":"Peterson","year":"2007","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jaut.2021.102609_bib141","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/eji.200425627","article-title":"Accumulation of intestinal intraepithelial lymphocytes in association with lack of polymeric immunoglobulin receptor","volume":"35","author":"Yamazaki","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2021.102609_bib142","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/ajg.2014.432","article-title":"The role of chronic norovirus infection in the enteropathy associated with common variable immunodeficiency","volume":"110","author":"Woodward","year":"2015","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jaut.2021.102609_bib143","first-page":"71","article-title":"Intestinal intraepithelial gamma\/delta T cells in B-cell deficiency","volume":"4","author":"Nilssen","year":"1993","journal-title":"Immunodeficiency"},{"key":"10.1016\/j.jaut.2021.102609_bib144","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1309\/AJCPEIILH2C0WFYE","article-title":"The significance of duodenal mucosal atrophy in patients with common variable immunodeficiency: a clinical and histopathologic study","volume":"138","author":"Biagi","year":"2012","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.jaut.2021.102609_bib145","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1365-2249.1994.tb06513.x","article-title":"Intestinal B cell defects in common variable immunodeficiency","volume":"95","author":"Herbst","year":"1994","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jaut.2021.102609_bib146","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s10875-013-9892-3","article-title":"The role of HLA DQ2 and DQ8 in dissecting celiac-like disease in common variable immunodeficiency","volume":"33","author":"Venhoff","year":"2013","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jaut.2021.102609_bib147","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/gut.45.5.662","article-title":"The clinicopathological features of extensive small intestinal CD4 T cell infiltration","volume":"45","author":"Carbonnel","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2021.102609_bib148","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/1097-0142(19940215)73:4<1286::AID-CNCR2820730425>3.0.CO;2-9","article-title":"Extensive small intestinal T-cell lymphoma of low-grade malignancy associated with a new chromosomal translocation","volume":"73","author":"Carbonnel","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.jaut.2021.102609_bib149","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1002\/1097-0142(19950401)75:7<1728::AID-CNCR2820750727>3.0.CO;2-9","article-title":"Relapsing oral and colonic ulcers with monoclonal T-cell infiltration. A low grade mucosal T-lymphoproliferative disease of the digestive tract","volume":"75","author":"Egawa","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.jaut.2021.102609_bib150","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1053\/gast.1996.v111.pm8780585","article-title":"Primary gastrointestinal T-cell lymphoma resembling multiple lymphomatous polyposis","volume":"111","author":"Hirakawa","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2021.102609_bib151","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.dld.2003.09.019","article-title":"Multiple lymphomatous polyposis of the colon originating from T-cells: a case report","volume":"36","author":"Isomoto","year":"2004","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.jaut.2021.102609_bib152","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068343","article-title":"Indolent small intestinal CD4+ T-cell lymphoma is a distinct entity with unique biologic and clinical features","volume":"8","author":"Margolskee","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.jaut.2021.102609_bib153","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s00428-007-0475-7","article-title":"Small intestinal CD4+ T-cell lymphoma: a rare distinctive clinicopathological entity associated with prolonged survival","volume":"451","author":"Svrcek","year":"2007","journal-title":"Virchows Arch."},{"key":"10.1016\/j.jaut.2021.102609_bib154","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1023\/B:DDAS.0000026297.25591.62","article-title":"T-cell lymphoproliferative disorder of the gut clinically mimicking celiac sprue","volume":"49","author":"Zivny","year":"2004","journal-title":"Dig. Dis. Sci."},{"issue":"7","key":"10.1016\/j.jaut.2021.102609_bib155","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.3324\/haematol.2019.230961","article-title":"Genetic and phenotypic characterization of indolent T-cell lymphoproliferative disorders of the gastrointestinal tract","volume":"Jul;105","author":"Soderquist","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.jaut.2021.102609_bib156","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/0016-5085(79)90389-5","article-title":"Clinical features and natural history of Crohn's disease","volume":"77","author":"Mekhjian","year":"1979","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaut.2021.102609_bib157","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1111\/j.1572-0241.2008.02000.x","article-title":"Presentation and disease course in early- compared to later-onset pediatric Crohn's disease","volume":"103","author":"Gupta","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jaut.2021.102609_bib158","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/ng.3760","article-title":"Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease","volume":"49","author":"de Lange","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jaut.2021.102609_bib159","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.autrev.2017.02.013","article-title":"A comprehensive review of inflammatory molecules","volume":"16","author":"Park","year":"2017","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2021.102609_bib160","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1136\/gut.2004.047092","article-title":"Increased gut permeability in Crohn's disease: is TNF the link?","volume":"53","author":"Gibson","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2021.102609_bib161","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nri1132","article-title":"The immunological and genetic basis of inflammatory bowel disease","volume":"3","author":"Bouma","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2021.102609_bib162","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1111\/j.1572-0241.2006.00840.x","article-title":"Diagnostic precision of anti-Saccharomyces cerevisiae antibodies and perinuclear antineutrophil cytoplasmic antibodies in inflammatory bowel disease","volume":"101","author":"Reese","year":"2006","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.jaut.2021.102609_bib163","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jaci.2003.10.047","article-title":"Eosinophilic gastrointestinal disorders (EGID)","volume":"113","author":"Rothenberg","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jaut.2021.102609_bib164","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/jgh.13463","article-title":"Eosinophilic gastroenteritis: a state-of-the-art review","volume":"32","author":"Zhang","year":"2017","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jaut.2021.102609_bib165","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1067\/mpd.2002.127663","article-title":"Eosinophil-associated gastrointestinal disorders: a world-wide-web based registry","volume":"141","author":"Guajardo","year":"2002","journal-title":"J. Pediatr."},{"key":"10.1016\/j.jaut.2021.102609_bib166","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0065-2776(01)78007-8","article-title":"Gastrointestinal eosinophils in health and disease","volume":"78","author":"Rothenberg","year":"2001","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.jaut.2021.102609_bib167","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00005792-197007000-00003","article-title":"Eosinophilic gastroenteritis","volume":"49","author":"Klein","year":"1970","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.jaut.2021.102609_bib168","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1136\/gut.31.1.54","article-title":"Eosinophilic gastroenteritis: a clinicopathological study of patients with disease of the mucosa, muscle layer, and subserosal tissues","volume":"31","author":"Talley","year":"1990","journal-title":"Gut"},{"key":"10.1016\/j.jaut.2021.102609_bib169","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1067\/mai.2002.122503","article-title":"Human milk-specific mucosal lymphocytes of the gastrointestinal tract display a TH2 cytokine profile","volume":"109","author":"Beyer","year":"2002","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jaut.2021.102609_bib170","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF01540983","article-title":"Evidence for an abnormal profile of interleukin-4 (IL-4), IL-5, and gamma-interferon (gamma-IFN) in peripheral blood T cells from patients with allergic eosinophilic gastroenteritis","volume":"14","author":"Jaffe","year":"1994","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jaut.2021.102609_bib171","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.humpath.2009.04.001","article-title":"Pathology of graft-versus-host disease in the gastrointestinal tract","volume":"40","author":"Washington","year":"2009","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.jaut.2021.102609_bib172","first-page":"367","article-title":"Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors","volume":"6","author":"Lerner","year":"1974","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.jaut.2021.102609_bib173","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/17474086.2017.1288566","article-title":"The gastrointestinal tract: properties and role in allogeneic hematopoietic stem cell transplantation","volume":"10","author":"Pessach","year":"2017","journal-title":"Expet Rev. Hematol."},{"key":"10.1016\/j.jaut.2021.102609_bib174","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1182\/blood-2013-02-485813","article-title":"Low Paneth cell numbers at onset of gastrointestinal graft-versus-host disease identify patients at high risk for nonrelapse mortality","volume":"122","author":"Levine","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2021.102609_bib175","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1182\/blood-2015-10-612747","article-title":"How I treat acute graft-versus-host disease of the gastrointestinal tract and the liver","volume":"127","author":"McDonald","year":"2016","journal-title":"Blood"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841121000172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841121000172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:27:48Z","timestamp":1760257668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841121000172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":175,"alternative-id":["S0896841121000172"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2021.102609","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune-mediated enteropathies: From bench to bedside","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2021.102609","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102609"}}